Available evidence suggests that some of the aforementioned biomarkers (leptin [15,16], adiponectin [17], resistin [18], and ghrelin [19,20]) may modulate the HPA axis, which is known to be hyperactive in patients with severe depression [21,22]. This evidence concerns the gene LEP and depressive symptom measurement.